Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H23NO3 |
Molecular Weight | 313.3908 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC(=C1)C(=O)CCN[C@@H](C)[C@H](O)C2=CC=CC=C2
InChI
InChIKey=GDYUVHBMFVMBAF-LIRRHRJNSA-N
InChI=1S/C19H23NO3/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2/h3-10,13-14,19-20,22H,11-12H2,1-2H3/t14-,19-/m0/s1
Originator
Approval Year
Sample Use Guides
Oral
Myocardial infarction, Angina pectoris
Adult: 8-24 mg tid.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14521236
Oxyfedrine was tested in vitro against 471 strains of bacteria from two Gram positive and fourteen Gram negative genera. The minimum inhibitory concentration (MIC) of oxyfedrine was determined by agar dilution method, which ranged from 50-200 ug/ml in most of the strains, while some strains were inhibited at even lower concentrations.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
C01DX53
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
||
|
NCI_THESAURUS |
C48149
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
||
|
WHO-VATC |
QC01DX53
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
||
|
NCI_THESAURUS |
C29707
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
||
|
WHO-VATC |
QC01DX03
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
||
|
WHO-ATC |
C01DX03
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000083303
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
D010099
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
C74199
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
OXYFEDRINE
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
DTXSID0023408
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
5489013
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
SUB09564MIG
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
7805
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
2030
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
15687-41-9
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
DB13398
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
m8331
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL1651913
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
DWL616XF1K
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY | |||
|
1975
Created by
admin on Sat Dec 16 16:30:26 GMT 2023 , Edited by admin on Sat Dec 16 16:30:26 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)